CD80 and cancer: As no large-scale dataset with matched structural biology and genomic readouts currently exists to perform systematic analyses, we focus on PD-1/PD-L1 and B7-1/CTLA-4 interacting proteins, important immune checkpoint protein interactors involved in cancer immunotherapies36.